PHILADELPHIA — The more allergies one has, the lower the risk of developing low- and high-grade glioma, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Rese…
COLUMBUS, Ohio — New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumors if equipped with an enzyme that helps them penetrate the tumor.
The enzyme, called …
Scientists have identified the type of cell that is at the origin of brain tumors known as oligodendrogliomas, which are a type of glioma — a category that defines the most common type of malignant brain tumor.
In a paper published in the Decemb…
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cell…
Investigators have demonstrated for the first time that the most common malignant childhood brain tumor, medulloblastoma, is actually several different diseases, each arising from distinct cells destined to become different structures. The breakthro…
St. Jude Children’s Research Hospital investigators have identified key components of a signaling pathway that controls the departure of neurons from the brain niche where they form and allows these cells to start migrating to their final dest…
ROCHESTER, Minn. — A new Mayo Clinic study (http://newsblog.mayoclinic.org/2008/12/03/brain-tumors-best-treatments-for-long-term-survival/) found that children with low-grade brain tumors (gliomas) (http://www.mayoclinic.org/brain-tumors/) who under…
LOS ANGELES (Nov. 4, 2010) — Nine years ago, scientists at Cedars-Sinai’s Maxine Dunitz Neurosurgical Institute detected a subtle shift occurring in the molecular makeup of the most aggressive type of brain tumors, glioblastoma multiforme. With fu…
JACKSONVILLE, Fla. — Researchers at Mayo Clinic in Florida have found that a molecule long believed to be a beneficial tumor suppressor — and thus a potential cancer drug target — appears to act as an oncogene in some lethal brain tumors.
…
Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that…
A new non-invasive therapy for liver cancer patients who cannot be helped by surgery or organ transplantation is being evaluated by researchers at the Indiana University School of Medicine. The Phase I clinical trial at the IU Cancer Center uses extracranial stereotactic radioablation (SRA) as a potential new treatment for hepatocelluar carcinoma, a cancer that originates in the liver, or for liver metastasis from other sites.
Despite advances in neurosurgery and radiation techniques, the prognosis for patients with intracranial glioma remains devastating. Now, researchers have identified a possible new treatment strategy for this common type of malignant brain tumor. Two studies funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) show that, in a mouse model, neural stem cells (NSCs) can be used to deliver therapeutic agents capable of killing glioma cells and their migrating tumor cells.
